Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study

被引:1
作者
Lock, Ashley. E. E. [1 ,2 ,3 ,4 ,5 ,9 ,10 ]
Gutierrez, G. Christina [1 ,2 ,3 ,4 ]
Hand, Elizabeth. O. O. [1 ,2 ,3 ,4 ]
Barthol, Colleen. A. A. [1 ,2 ,3 ,4 ]
Attridge, Rebecca. L. L. [6 ,7 ,8 ]
机构
[1] Univ Hlth San Antonio, Dept Pharmacotherapy, San Antonio, TX USA
[2] Univ Hlth San Antonio, Pharm Serv, San Antonio, TX USA
[3] Univ Texas Austin, Coll Pharm, Div Pharmacotherapy, Austin, TX USA
[4] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX USA
[5] UT Hlth San Antonio, Long Sch Med, Dept Emergency Med, San Antonio, TX USA
[6] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA
[7] UT Hlth San Antonio, Div Pulm Dis & Crit Care, Dept Med, San Antonio, TX USA
[8] Craneware Grp, Deerfield Beach, FL USA
[9] Univ Hlth San Antonio, Dept Pharmacotherapy, 4502 Med Dr, MS 102-1, San Antonio, TX 78229 USA
[10] Univ Hlth San Antonio, Pharm Serv, 4502 Med Dr, MS 102-1, San Antonio, TX 78229 USA
关键词
corticosteroids; hydrocortisone; fludrocortisone; sepsis; septic shock; SURVIVING SEPSIS CAMPAIGN; LOW-DOSE HYDROCORTISONE; INTERNATIONAL GUIDELINES; CORTICOSTEROID TREATMENT; MANAGEMENT; VASOPRESSIN; MORTALITY; REVERSAL; ADULTS;
D O I
10.1177/10600280231164210
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Trials evaluating hydrocortisone (HC) for septic shock are conflicting with all finding decreased time to shock reversal but few with mortality difference. Those with improved mortality included fludrocortisone (FC), but it is unknown if FC affected the outcome or is coincidental as there are no comparative data. Objective: The objective of this study was to determine the effectiveness and safety of FC + HC versus HC alone as adjunctive therapy in septic shock. Methods: A single-center, retrospective cohort study was conducted of medical intensive care unit (ICU) patients with septic shock refractory to fluids and vasopressors. Patients receiving FC + HC were compared with those receiving HC. Primary outcome was time to shock reversal. Secondary outcomes included in-hospital, 28-, and 90-day mortality; ICU and hospital length of stay (LOS); and safety. Results: There were 251 patients included (FC + HC, n = 114 vs HC, n = 137). There was no difference in time to shock reversal (65.2 vs 71 hours; P = 0.24). Cox proportional hazards model showed time to first corticosteroid dose, full-dose HC duration, and use of FC + HC were associated with shorter shock duration, while time to vasopressor therapy was not. However, in 2 multivariable models controlling for covariates, use of FC + HC was not an independent predictor of shock reversal at greater than 72 hours and in-hospital mortality. No differences were seen in hospital LOS or mortality. Hyperglycemia occurred more frequently with FC + HC (62.3% vs 45.6%; P = 0.01). Conclusion and Relevance: FC + HC was not associated with shock reversal at greater than 72 hours or decreased in-hospital mortality. These data may be useful for determining corticosteroid regimen in patients with septic shock refractory to fluids and vasopressors. Future prospective, randomized studies are needed to further evaluate the role of FC in this patient population.
引用
收藏
页码:1375 / 1388
页数:14
相关论文
共 28 条
[1]   Hydrocortisone plus Fludrocortisone for Adults with Septic Shock [J].
Annane, D. ;
Renault, A. ;
Brun-Buisson, C. ;
Megarbane, B. ;
Quenot, J. -P. ;
Siami, S. ;
Cariou, A. ;
Forceville, X. ;
Schwebel, C. ;
Martin, C. ;
Timsit, J. -F. ;
Misset, B. ;
Benali, M. Ali ;
Colin, G. ;
Souweine, B. ;
Asehnoune, K. ;
Mercier, E. ;
Chimot, L. ;
Charpentier, C. ;
Francois, B. ;
Boulain, T. ;
Petitpas, F. ;
Constantin, J. -M. ;
Dhonneur, G. ;
Baudin, F. ;
Combes, A. ;
Bohe, J. ;
Loriferne, J. -F. ;
Amathieu, R. ;
Cook, F. ;
Slama, M. ;
Leroy, O. ;
Capellier, G. ;
Dargent, A. ;
Hissem, T. ;
Maxime, V. ;
Bellissant, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :809-818
[2]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[3]   Why My Steroid Trials in Septic Shock Were "Positive" [J].
Annane, Djillali .
CRITICAL CARE MEDICINE, 2019, 47 (12) :1789-1793
[4]   The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update [J].
Annane, Djillali .
FRONTIERS IN ENDOCRINOLOGY, 2016, 7
[5]   Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults A Randomized Controlled Trial [J].
Annane, Djillali ;
Cariou, Alain ;
Maxime, Virginie ;
Azoulay, Elie ;
D'honneur, Gilles ;
Timsit, Jean Francois ;
Cohen, Yves ;
Wolf, Michel ;
Fartoukh, Muriel ;
Adrie, Christophe ;
Santre, Charles ;
Bollaert, Pierre Edouard ;
Mathonet, Armelle ;
Amathieu, Roland ;
Tabah, Alexis ;
Clec'h, Christophe ;
Mayaud, Julien ;
Lejeune, Julie ;
Chevret, Sylvie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (04) :341-348
[6]   Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study [J].
Bonnin, Sophia ;
Radosevich, John J. ;
Lee, Yong Gu ;
Feldman, Jeremy P. ;
Barletta, Jeffrey F. .
JOURNAL OF CRITICAL CARE, 2021, 62 :111-116
[7]  
Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI [10.1007/s00134-007-0934-2, 10.1007/s00134-008-1040-9, 10.1097/01.CCM.0000298158.12101.41]
[8]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :536-555
[9]  
Evans L, 2021, INTENS CARE MED, V47, P1181, DOI [10.1097/CCM.0000000000005337, 10.1007/s00134-021-06506-y]
[10]   Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis A Systematic Review and Meta-analysis [J].
Fang, Fang ;
Zhang, Yu ;
Tang, Jingjing ;
Lunsford, L. Dade ;
Li, Tiangui ;
Tang, Rongrui ;
He, Jialing ;
Xu, Ping ;
Faramand, Andrew ;
Xu, Jianguo ;
You, Chao .
JAMA INTERNAL MEDICINE, 2019, 179 (02) :213-223